Linagliptin

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1247 publications

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Journal: Disease-a-month : DM
Published: June 12, 2026

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid in an Elderly Woman With Type 2 Diabetes Mellitus: A Case Report.

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid in an Elderly Woman With Type 2 Diabetes Mellitus: A Case Report.

Journal: Cureus
Published: June 11, 2026

Antidiabetes agents and risk of incident depression in 686,522 people with type 2 diabetes mellitus: A 20-year population-based cohort study.

Antidiabetes agents and risk of incident depression in 686,522 people with type 2 diabetes mellitus: A 20-year population-based cohort study.

Journal: Psychological medicine
Published: June 08, 2026

In vivo genotoxicity assessment of oral antidiabetic drugs in Drosophila melanogaster.

In vivo genotoxicity assessment of oral antidiabetic drugs in Drosophila melanogaster.

Journal: Journal of toxicology and environmental health. Part A
Published: June 07, 2026

Determination of S-enantiomer in linagliptin by supercritical fluid chromatography-ultraviolet detection

Determination of S-enantiomer in linagliptin by supercritical fluid chromatography-ultraviolet detection

Journal: Se pu = Chinese journal of chromatography
Published: June 05, 2026

Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic review.

Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic review.

Journal: Drug metabolism reviews
Published: May 06, 2026

Concurrent Metformin-Associated Lactic Acidosis and Euglycemic Diabetic Ketoacidosis Without Sodium-Glucose Cotransporter 2 Inhibitor Exposure: A Case Report and Literature Review.

Concurrent Metformin-Associated Lactic Acidosis and Euglycemic Diabetic Ketoacidosis Without Sodium-Glucose Cotransporter 2 Inhibitor Exposure: A Case Report and Literature Review.

Journal: Cureus
Published: April 12, 2026

Linagliptin protects diabetic rats' cognition.

Linagliptin protects diabetic rats' cognition.

Journal: Lab animal
Published: April 02, 2026

An integrative machine learning and structure-driven drug repositioning strategy for human IRAK4-targeted cancer therapy.

An integrative machine learning and structure-driven drug repositioning strategy for human IRAK4-targeted cancer therapy.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 26, 2026

Discrimination of crystal polymorphism in active pharmaceutical ingredients using time-domain 1H NMR relaxation combined with multivariate statistical process control.

Discrimination of crystal polymorphism in active pharmaceutical ingredients using time-domain 1H NMR relaxation combined with multivariate statistical process control.

Journal: International journal of pharmaceutics
Published: March 13, 2026

Comparative thromboembolic risk and polypharmacy-related drug-drug interaction signals among antidiabetic medications: a large-scale FAERS pharmacovigilance study.

Comparative thromboembolic risk and polypharmacy-related drug-drug interaction signals among antidiabetic medications: a large-scale FAERS pharmacovigilance study.

Journal: Frontiers in pharmacology
Published: March 09, 2026

SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis.

SGLT2 Inhibitor Use and Cardiorenal Outcomes in Type 2 Diabetes With Liver Cirrhosis.

Journal: JAMA network open
Published: February 23, 2026
Showing 1-12 of 1,247

Last Updated: 06/30/2026